“…BACKGROUND: Pneumonia is one of the principal reasons for incidence and death in the world. The former research mainly concentrated on specific sources of patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The study period lasted from the first claim until death, the end of data availability, a drug switch, or discontinuation of therapy, whichever came first. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Using data from a phase III, multicenter, randomized clinical trial (NCT02137772, registered May 14, 2014), this study assessed CMV-associated and all-cause re-hospitalizations at weeks 14, 24, and 48 post-transplant among recipients of letermovir versus placebo. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Hospital-based data from 35,730 stroke cases were retrieved from selected private and public hospitals between January 2014 and December 2018. The model used, QR provides richer information about the predictors on costs. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Pneumonia remains the leading cause of death among children <5 years of age beyond the neonatal period in Thailand. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…PATIENTS AND METHODS: Using the surveillance, epidemiology, and end results (SEER) database, we identified 461 patients of pulmonary pleomorphic carcinoma from 2004 to 2014 including clinicopathological characteristics, treatment modalities and outcome data. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: We conducted a case-control study comparing all patients who developed Stroke/TIA from 2014 to 2019 following a cancer diagnosis at King Hussein Cancer Center (KHCC), matched to Stroke/TIA-free controls based on age, gender, and cancer site. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The pan-cancer hazard ratio for death in the presence of pre-existing cardiovascular diseases was 1.28 (95% CI: 1.18-1.40). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…PATIENTS AND METHODS: This retrospective cohort study used data extracted from the Swedish national trauma registry and included adults admitted with severe TBI between January 2014 and December 2018. The cohort was divided into two subgroups based on whether they were treated at a trauma center or non-trauma center. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Using electronic medical records in Hong Kong, we identified 24,576 patients with incident depression between 2014 and 2016 without autoimmune history and followed up from diagnosis to death or December 2020 to identify TRD status and autoimmune incidence. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Potentially avoidable risk factors continue to cause unnecessary disability and premature death in older people. Health risk assessment (HRA), a method successfully used in working-age populations, is a promising method for cost-effective health promotion and preventive care in older individuals, but the long-term effects of this approach are unknown. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Patients were followed up until March 2014. RESULTS: In all, 124 patients who were ≥80 years of age had CKD Stage 4 (115 patients) or 5 (9 patients). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The last date of follow-up was defined as the date of death or 31 December 2015, whichever came first. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The present study aimed to assess the long-term influence of disability on death in the elderly based on a longitudinal study. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: We conducted a retrospective cohort study (2014–2022) on consecutive VA-ECMO patients in the medical and infectious disease intensive care unit of Bichat-Claude Bernard University Hospital, Paris, France. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In terms of progression-free survival analysis, patients with a lower value of PET-Skewness (threshold < 0.2014; hazard ratio (HR) 0.17, 95% CI 0.06–0.46; p < 0.001) and higher value of PET-Median (threshold > 0.5233; HR 0.23, 95% CI 0.11–0.49; p < 0.001) had a significantly lower probability of disease progression or death. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…For those who reconsented, follow-up for incident cancers continued until December 31, 2014, or death, whichever occurred first. Data analysis for this secondary analysis was performed from April 2022 through November 2022. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We identified 18 cases of NSCLCs with EGFR/ERBB2 ex20 ins/dup and correlated the findings with clinical and morphologic information including programed death-ligand 1 (PD-L1) expression. METHODS: A total of 536 NSCLC cases tested at our institution between 2014 and 2023 were reviewed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Adults aged 18 years or older with a diagnosis of CP and without severe CKD (stages IV+) and liver disease were identified from the calendar year 2013 and were subsequently followed from January 1, 2014, to death, severe CKD, liver disease, loss to follow-up, or end of study period (December 31, 2017). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: This study analyzed 312 early-stage HCC patients who were hospitalized and underwent ablative treatment in Beijing You’an Hospital, Capital Medical University, from 1 January 2014 to 1 January 2019. The primary endpoint was the recurrence-free survival (RFS), calculated from treatment initiation to cancer recurrence, whereas the overall survival (OS) was measured from treatment initiation to death or last follow-up. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso